Published in Parasitol Res on October 01, 1999
Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides. Nucleic Acids Res (2004) 0.85
Improved hybridisation potential of oligonucleotides comprising O-methylated anhydrohexitol nucleoside congeners. Nucleic Acids Res (2001) 0.75
Ribozyme cleavage of Plasmodium falciparum gyrase A gene transcript affects the parasite growth. Parasitol Res (2008) 0.75
Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods (1988) 7.74
Priorities among recommended clinical preventive services. Am J Prev Med (2001) 3.70
Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation (2003) 3.40
The evolving role of prevention in health care: contributions of the U.S. Preventive Services Task Force. Am J Prev Med (2001) 2.31
Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci U S A (1982) 2.29
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob Agents Chemother (1987) 2.24
Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. J Virol Methods (1987) 2.10
Methods for priority setting among clinical preventive services. Am J Prev Med (2001) 2.05
Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J Biol Chem (1989) 1.89
Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands. J Med Chem (2000) 1.85
Molecular dipstick test for diagnosis of sleeping sickness. J Clin Microbiol (2006) 1.84
Preparation of a mannopentaose, mannohexaose, and mannoheptaose from Saccharomyces cerevisiae mannan. Biochemistry (1968) 1.79
Developing evidence-based clinical practice guidelines: lessons learned by the US Preventive Services Task Force. Annu Rev Public Health (1996) 1.76
Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. Proc Natl Acad Sci U S A (1989) 1.74
Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Proc Natl Acad Sci U S A (1991) 1.67
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem Biophys Res Commun (1987) 1.67
Mandated coverage for cancer-screening services: whose guidelines do states follow? Am J Prev Med (2000) 1.66
The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med (1994) 1.60
Modifications in lignin and accumulation of phenolic glucosides in poplar xylem upon down-regulation of caffeoyl-coenzyme A O-methyltransferase, an enzyme involved in lignin biosynthesis. J Biol Chem (2000) 1.58
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents. J Med Chem (1987) 1.53
The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol (1988) 1.45
Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues. Biochem Pharmacol (1988) 1.37
Novel species of tRNA. Nature (1971) 1.30
Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun (2000) 1.29
A comparison of yeast mannans and phosphomannans by acetolysis. Biochemistry (1968) 1.28
Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro. Biochem Biophys Res Commun (1987) 1.27
RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA). Nucleic Acids Res (2001) 1.25
Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J Med Chem (1999) 1.25
The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides. Mol Pharmacol (1987) 1.21
Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine. Biochem Biophys Res Commun (1986) 1.19
Cloning and expression of a prokaryotic enzyme, arginine deiminase, from a primitive eukaryote Giardia intestinalis. J Biol Chem (1998) 1.17
Incorporation of hexose nucleoside analogues into oligonucleotides: synthesis, base-pairing properties and enzymatic stability. Nucleic Acids Res (1992) 1.16
Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways. Oncogene (2006) 1.15
Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry (1997) 1.13
Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands. Proteins (1998) 1.11
The characterization of phosphoseryl tRNA from lactating bovine mammary gland. Nucleic Acids Res (1977) 1.11
Synthesis and antiviral activity of acyclic nucleosides with a 3(S),5-dihydroxypentyl or 4(R)-methoxy-3(S),5-dihydroxypentyl side chain. J Med Chem (1992) 1.10
Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: toward new drugs for the treatment of sleeping sickness. J Med Chem (1994) 1.10
Purification and properties of a translation inhibitor from wheat germ. Biochemistry (1979) 1.09
9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo. Proc Natl Acad Sci U S A (1991) 1.09
Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation. Arch Dermatol (1997) 1.08
Steroid injection for heel pain: evidence of short-term effectiveness. A randomized controlled trial. Rheumatology (Oxford) (1999) 1.06
Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-beta-D-erythro-hexopyranosyl nucleosides. Nucleic Acids Res (1993) 1.06
Use of automated external defibrillators for children: an update: an advisory statement from the pediatric advanced life support task force, International Liaison Committee on Resuscitation. Circulation (2003) 1.06
Point mutations in the 5' ICR and anticodon region of a Drosophila tRNAArg gene decrease in vitro transcription. Nucleic Acids Res (1985) 1.06
Influence of the incorporation of (S)-9-(3,4-dihydroxybutyl)adenine on the enzymatic stability and base-pairing properties of oligodeoxynucleotides. Nucleic Acids Res (1991) 1.05
Rat osteogenic sarcoma cells: comparison of the effects of prostaglandins E1, E2, I2 (prostacyclin), 6-keto F1alpha and thromboxane B2 on cyclic AMP production and adenylate cyclase activity. Biochem Biophys Res Commun (1978) 1.04
Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis. J Biol Chem (1993) 1.04
Screening and treating adults for lipid disorders. Am J Prev Med (2001) 1.02
Peroxisomal beta-oxidation of 2-methyl-branched acyl-CoA esters: stereospecific recognition of the 2S-methyl compounds by trihydroxycoprostanoyl-CoA oxidase and pristanoyl-CoA oxidase. FEBS Lett (1996) 1.01
Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. J Med Chem (1986) 1.01
Pedigree analysis of 5 swine breeds in the United States and the implications for genetic conservation. J Anim Sci (2010) 1.00
Student perceptions of tutor skills in problem-based learning tutorials. Med Educ (2002) 1.00
The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochem Biophys Res Commun (1987) 1.00
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes. Int J Cancer (2000) 1.00
Incorporation of 2'-amido-nucleosides in oligodeoxynucleotides and oligoribonucleotides as a model for 2'-linked conjugates. Nucleic Acids Res (1995) 0.99
The nucleotide sequence of asparagine tRNA from Escherichia coli. Nucleic Acids Res (1976) 0.99
Prostaglandins as mediators of bone resorption in renal and breast tumours. Clin Sci (Lond) (1980) 0.99
Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus. J Biol Chem (1991) 0.99
Enzymatic incorporation in DNA of 1,5-anhydrohexitol nucleotides. Biochemistry (2000) 0.98
Base pairing of anhydrohexitol nucleosides with 2,6-diaminopurine, 5-methylcytosine and uracil asbase moiety. Nucleic Acids Res (1999) 0.98
Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J Mol Biol (1999) 0.97
Isolation of Escherichia coli precursor tRNAs containing modified nucleoside Q. J Biol Chem (1977) 0.97
Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Br J Cancer (1977) 0.96
Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo. Nucleic Acids Res (1984) 0.96
Clinical practice guidelines in practice and education. J Gen Intern Med (1997) 0.95
A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med (1993) 0.95
Long-term cultivation of Plasmodium falciparum in media with commercial non-serum supplements. Parasitol Res (1997) 0.95
An ATP-dependent inhibition of protein synthesis in ascites cell extracts by wheat germ protein. Biochim Biophys Acta (1977) 0.94
Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice. Cancer Res (1986) 0.94
Nonenzymatic synthesis of RNA and DNA oligomers on hexitol nucleic acid templates: the importance of the A structure. J Am Chem Soc (1999) 0.94
The effect of oestrogens on the response of bone to parathyroid hormone in vitro. J Endocrinol (1972) 0.94
(D)- and (L)-cyclohexenyl-G, a new class of antiviral agents: synthesis, conformational analysis, molecular modeling, and biological activity. Nucleosides Nucleotides Nucleic Acids (2001) 0.94
An acyclic 5-nitroindazole nucleoside analogue as ambiguous nucleoside. Nucleic Acids Res (1995) 0.92
Differential inhibitory effects of several pyrimidine 2',3'-dideoxynucleoside 5'-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases. Mol Pharmacol (1989) 0.92
Synthesis and structure-activity relationships of analogs of 2'-deoxy-2'-(3-methoxybenzamido)adenosine, a selective inhibitor of trypanosomal glycosomal glyceraldehyde-3-phosphate dehydrogenase. J Med Chem (1995) 0.91
Multiple regression and principal components analysis of puberty and growth in cattle. J Anim Sci (1988) 0.90
Solution structure of a HNA-RNA hybrid. Chem Biol (2000) 0.90
Interventions for treating plantar heel pain. Cochrane Database Syst Rev (2000) 0.90
Avalanche deaths in the United States: a 45-year analysis. Wilderness Environ Med (1999) 0.90
Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides. Nucleic Acids Res (2001) 0.90
Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1. J Med Chem (1996) 0.89
Subfamilies of serine tRNA genes in the bovine genome. Mol Gen Genet (1991) 0.89
Nucleotide sequence of Lactobacillus viridescens 5S RNA. Nucleic Acids Res (1980) 0.89
5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication. J Med Chem (1991) 0.89
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside. Biochem Pharmacol (1988) 0.89
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet (2006) 0.89
Saturation mutagenesis of the Drosophila tRNA(Arg) gene B-Box intragenic promoter element: requirements for transcription activation and stable complex formation. Nucleic Acids Res (1990) 0.88
Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides. Antisense Nucleic Acid Drug Dev (1999) 0.88
The U.S. Preventive Services Task Force: putting evidence-based medicine to work. Clin Obstet Gynecol (1998) 0.87
Structural characterization of N-linked oligosaccharides from cellobiohydrolase I secreted by the filamentous fungus Trichoderma reesei RUTC 30. Eur J Biochem (1997) 0.86
Inhibition of Plasmodium falciparum proliferation in vitro by ribozymes. J Biol Chem (1997) 0.86
Resolution of aristeromycin enantiomers. J Med Chem (1985) 0.86
RNA as a target for drug design, the example of Tat-TAR interaction. Curr Top Med Chem (2002) 0.86
Nonenzymatic template-directed reactions on altritol oligomers, preorganized analogues of oligonucleotides. Chemistry (2000) 0.86
Rat osteogenic sarcoma cells:effects of some prostaglandins, their metabolites and analogues on cyclic AMP production. Prostaglandins (1977) 0.85